The fifth unbeatable stock I'm eager to add to my portfolio in 2025 is none other than Dow Jones Industrial Average member ...

Solasia Pharma KK ( (JP:4597) ) has issued an announcement.

Much has been written about the demise of the traditional pharmaceutical sales model and the “Complex Buying Environment” that now pervades within our industry. The reasons have been well docu ...

President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tariffs on ...

Lawyers claim J&J 'knew for decades' that there was allegedly asbestos present in its talc products, but the US pharmaceutical ... The company discontinued sales of talc-based baby powder in ...

Veru ( ) just unveiled an update. Veru Inc. announced the sale of its FC2 Female Condom business to Clear Future, Inc. for $18 million. This divestment allows Veru to focus on its ...

plaintiffs' lawyers are pressuring pharmaceutical companies for a large settlement. [22] Second, the NVICP does not cover all vaccines only those routinely recommended for all children.

In contrast to drug sales in the private sector, the prices paid by federal purchasers are subject to a complex array of regulations which generate deeper discounts. There are five federal ...

While pharmaceutical sales in many mature markets are showing stagnant growth or even regressions, the sales estimates in the emerging markets point to continued growth. In fact, it is estimated ...

Electric-vehicle makers and investors should buckle up for 2025, because President-elect Trump could eliminate EV purchase tax credits for as much as $7,500 a vehicle. That would be a de facto price ...